glp-1 ibd Receptor Agonists Reduce Colorectal Cancer Risk in Populations Ozempic and Crohn's Disease: Could

February 10, 2026

Curcumin Supplements Curcumin is the active compound in turmeric, well-known for its anti-inflammatory properties

Liraglutide, injectable semaglutide, and dulaglutide have FDA-recognized cardiovascular risk reduction in patients with established cardiovascular disease, while Wegovy is indicated for cardiovascular risk reduction in adults with established cardiovascular disease and either overweight or obesity

Data analysis All data are presented as meanstandard error of the mean of at least two independent experiments

Long-term maintenance On stable long-term dosing, injection site reactions should be rare